Basit öğe kaydını göster

dc.contributor.authorKASAPÇOPUR, Özgür
dc.contributor.authorSahin, Sezgin
dc.contributor.authorBARUT, Kenan
dc.contributor.authorOmeroglu, Rukiye Eker
dc.contributor.authorKoker, Oya
dc.contributor.authorADROVIC YILDIZ, AMRA
dc.contributor.authorYildiz, Mehmet
dc.date.accessioned2021-03-03T10:46:12Z
dc.date.available2021-03-03T10:46:12Z
dc.date.issued2019
dc.identifier.citationKoker O., ADROVIC YILDIZ A., Sahin S., Yildiz M., BARUT K., Omeroglu R. E. , KASAPÇOPUR Ö., "Evaluation of six-minute walk test in juvenile systemic sclerosis", Rheumatology International, cilt.39, sa.2, ss.293-300, 2019
dc.identifier.issn0172-8172
dc.identifier.othervv_1032021
dc.identifier.otherav_247d9a47-add3-4c26-aad7-ce1a7d739eeb
dc.identifier.urihttp://hdl.handle.net/20.500.12627/29439
dc.identifier.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85055705979&origin=inward
dc.identifier.urihttps://doi.org/10.1007/s00296-018-4185-z
dc.description.abstract© 2018, Springer-Verlag GmbH Germany, part of Springer Nature.The objective is to evaluate the walking distance and oxygen desaturation during the six-minute walk test and to establish correlations between the test results and other clinical findings so to assess the reliability of the test for evaluation of children with juvenile systemic sclerosis (jSSc). A total of 25 jSSc, 27 juvenile systemic lupus erythematosus (jSLE), and 30 healthy controls were included. The test is conducted according to the guidelines recommended by the American Thoracic Society, standardized in 2002. Median values of walking distances were 470 (415–580) m in jSSc; 518 (376–618) m in jSLE; and 562 (493.5–618) m in healthy controls. jSSc patients walked significantly less distance comparing to controls (p < 0.001). jSSc patients with lung involvement walked less than those without lung involvement [463.2 (418–565) m vs. 491.5 (415–580) m], but without a significant difference (p = 0.82). The frequency of lower extremity pain during and after the test was significantly higher in the jSSc cohort compared to both control groups (p = 0.001). Patients with myalgia were found to walk less than those without myalgia [446.5 (415–538) m vs. 493.5 (428–580) m] (p = 0.04). Patients with jSSc have limited walking distances. Despite the decreased walking distance among jSSc patients with ILD and/or PAH, the limited number of patients makes the results inappropriate for interpretation. Low extremity pain influences the walking capacity of jSSc patients.
dc.language.isoeng
dc.subjectİmmünoloji ve Romatoloji
dc.subjectİç Hastalıkları
dc.subjectDahili Tıp Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectROMATOLOJİ
dc.titleEvaluation of six-minute walk test in juvenile systemic sclerosis
dc.typeMakale
dc.relation.journalRheumatology International
dc.contributor.departmentİstanbul Üniversitesi-Cerrahpaşa , Cerrahpaşa Tıp Fakültesi , Çocuk Sağlığı Ve Hastalıkları Ana Bilim Dalı
dc.identifier.volume39
dc.identifier.issue2
dc.identifier.startpage293
dc.identifier.endpage300
dc.contributor.firstauthorID262052


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster